The Timing of Surgery and Symptom Resolution in Patients Undergoing Transforaminal Lumbar Interbody Fusion for Lumbar Degenerative Disk Disease and Radiculopathy

被引:14
|
作者
Villavicencio, Alan T. [1 ,2 ]
Nelson, E. Lee [1 ]
Rajpal, Sharad
Burneikiene, Sigita [1 ,2 ]
机构
[1] Boulder Neurosurg Associates, 4743 Arapahoe Ave,Suite 202, Boulder, CO 80303 USA
[2] Justin Parker Neurol Inst, Boulder, CO USA
来源
CLINICAL SPINE SURGERY | 2017年 / 30卷 / 06期
关键词
clinical outcomes; duration of symptoms; prospective; clinical study; radiculopathy; transforaminal lumbar interbody fusion (TLIF); OUTCOMES-RESEARCH-TRIAL; SPINAL STENOSIS; CONSERVATIVE TREATMENT; PROSPECTIVE COHORT; PROGNOSTIC-FACTORS; HERNIATION; DURATION; MANAGEMENT; SCIATICA; PAIN;
D O I
10.1097/BSD.0000000000000392
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: Success rates of surgical interventions for lumbar disorders vary significantly depending on multiple factors and, among them, the duration of symptoms. It is not clear whether there is a "cutoff" time when decompression and fusion surgery becomes less effective in the conditions with chronic nerve root compression symptomatology. The main objective of this study was to analyze whether duration of symptoms has any effect on clinical outcomes and primarily resolution of radicular pain symptoms due to degenerative disk disease and stenosis with spondylolisthesis in patients undergoing transforaminal lumbar interbody fusion (TLIF). Methods: The prospective observational study was performed. Eighty-four patients with radicular symptoms due to degenerative disk disease and stenosis with spondylolisthesis with no previous fusion surgeries and undergoing 1- to 3-level TLIF surgery were enrolled. Fifteen patients (18%) were lost to follow-up and were excluded from this analysis leaving a total of 69 patients. Standardized questionnaires were used to analyze clinical outcomes and were administered preoperatively within 3 months of scheduled surgery, and postoperatively at 3, 6, 12, and 24 months. To emphasize the change in clinical outcome scores, the relevant scores were calculated as the ratio of minimal clinically important difference values and change scores. The change scores were calculated by subtracting the postoperative scores from the baseline scores. Multiple regression analyses were conducted to examine the relationship of the duration of symptoms and relevant minimal clinically important difference ratio values while controlling for independent variables. Further, a comparison between 2 groups of patients was performed to analyze the changes of clinical outcomes for the patients who underwent fusion within <24 months versus >= 24 months. Results: It was determined that the duration of symptoms was a significant predictor of better leg pain resolution (P=0.018), but not back pain resolution (P=0.27), or improvement in ODI (P=0.10) and SF-36 PCS scores (P=0.19). The patients with shorter duration of symptoms had significantly better radicular symptom resolution (P=0.032) compared with patients who waited at least 24 months or longer to undergo fusion. Conclusions: A shorter duration of symptoms was found to be a statistically significant predictor for better resolution of radicular symptoms in patients undergoing TLIF for painful degenerative disk disease and stenosis with spondylolisthesis.
引用
收藏
页码:E765 / E769
页数:5
相关论文
共 50 条
  • [21] Correction to: Lumbar degenerative disease treated by percutaneous endoscopic transforaminal lumbar interbody fusion or minimally invasive surgery-transforaminal lumbar interbody fusion: a case-matched comparative study
    You-Di Xue
    Wen-Bo Diao
    Chao Ma
    Jie Li
    Journal of Orthopaedic Surgery and Research, 17
  • [22] Effect of Single-Level Transforaminal Lumbar Interbody Fusion on Segmental and Overall Lumbar Lordosis in Patients with Lumbar Degenerative Disease
    Cheng, Xiaofei
    Zhang, Feng
    Zhang, Kai
    Sun, Xiaojiang
    Zhao, Changqing
    Li, Hua
    Li, Yan Michael
    Zhao, Jie
    WORLD NEUROSURGERY, 2018, 109 : E244 - E251
  • [23] Minimally Invasive Transforaminal Lumbar Interbody Fusion for the Treatment of Degenerative Lumbar Diseases
    Fan Shunwu
    Zhao Xing
    Zhao Fengdong
    Fang Xiangqian
    SPINE, 2010, 35 (17) : 1615 - 1620
  • [24] Comparison of Outcomes of Anterior, Posterior, and Transforaminal Lumbar Interbody Fusion Surgery at a Single Lumbar Level with Degenerative Spinal Disease
    Lee, Nam
    Kim, Keung Nyun
    Yi, Seong
    Ha, Yoon
    Shin, Dong Ah
    Yoon, Do Heum
    Kim, Keun Su
    WORLD NEUROSURGERY, 2017, 101 : 216 - 226
  • [25] The relation between zoledronic acid infusion and interbody fusion in patients undergoing transforaminal lumbar interbody fusion surgery
    Chao Li
    Hui-Ren Wang
    Xi-Lei Li
    Xiao-Gang Zhou
    Jian Dong
    Acta Neurochirurgica, 2012, 154 : 731 - 738
  • [27] Minimally invasive surgery for degenerative spondylolisthesis: transforaminal or oblique lumbar interbody fusion
    Sheng, Sun-Ren
    Geng, Yi-Bo
    Zhou, Kai-Liang
    Wu, Ai-Min
    Wang, Xiang-Yang
    Ni, Wen-Fei
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2020, 9 (01) : 45 - 51
  • [28] The relation between zoledronic acid infusion and interbody fusion in patients undergoing transforaminal lumbar interbody fusion surgery
    Li, Chao
    Wang, Hui-Ren
    Li, Xi-Lei
    Zhou, Xiao-Gang
    Dong, Jian
    ACTA NEUROCHIRURGICA, 2012, 154 (04) : 731 - 738
  • [29] Perioperative complications in patients undergoing open transforaminal lumbar interbody fusion as a revision surgery
    Khan, Imad Saeed
    Sonig, Ashish
    Thakur, Jai Deep
    Bollam, Papireddy
    Nanda, Anil
    JOURNAL OF NEUROSURGERY-SPINE, 2013, 18 (03) : 260 - 264
  • [30] Posterior corrective surgery with a multilevel transforaminal lumbar interbody fusion and a rod rotation maneuver for patients with degenerative lumbar kyphoscoliosis
    Matsumura, Akira
    Namikawa, Takashi
    Kato, Minori
    Ozaki, Tomonori
    Hori, Yusuke
    Hidaka, Noriaki
    Nakamura, Hiroaki
    JOURNAL OF NEUROSURGERY-SPINE, 2017, 26 (02) : 150 - 157